Avapritinib and Trospium / Xanomeline: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Avapritinib
Trospium / Xanomeline
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Your medicine Cobenfy (which contains xanomeline) can briefly slow down an enzyme in your gut called CYP3A4. That same enzyme helps break down your cancer medicine Ayvakit (avapritinib). When the enzyme is slowed, a little more Ayvakit may get absorbed into your body.
In plain terms, that could mean stronger effects and more side effects from Ayvakit, such as swelling, tiredness, nausea, or dizziness. The good news is this concern is based on how the drugs work in theory, not on reported problems. Your care team can manage it easily by watching you a bit more closely and adjusting your dose if needed. Let them know if you feel worse than usual.
Direction: Xanomeline (in Cobenfy) transiently inhibits gut CYP3A4 (not systemic), potentially increasing exposure of oral sensitive CYP3A4 substrates. Avapritinib is a CYP3A4 substrate, so its AUC/Cmax may rise, increasing frequency/severity of dose-related adverse effects (edema, cytopenias, fatigue, GI effects, cognitive/CNS events).
- Mechanism: local intestinal CYP3A4 inhibition
- Evidence: theoretical
- Onset: unspecified
- Magnitude: not quantified
Management: Monitor for increased avapritinib-related adverse reactions. Dose may be individualized by the oncology team; consider closer clinical follow-up if co-administered.
What happens
Increased oral sensitive CYP3A4 substrate exposure and an increased risk on severity and frequency of sensitive CYP3A4 substrate-related adverse reactions
Interaction Deep Dive
Within the gut, xanomeline produces a temporary, local inhibition of CYP3A4, though this effect does not extend systemically. When it is taken together with oral medications that act as sensitive substrates of CYP3A4, the exposure to those oral sensitive CYP3A4 substrates may rise. As a result, adverse reactions associated with these substrates could occur more frequently and/or with greater severity. In cases of concurrent administration, patients should be observed for any increase in the frequency and/or severity of adverse reactions tied to oral drugs that are sensitive substrates of CYP3A41.
Why it happens (mechanism)
Inhibition of CYP3A4-substrate metabolism by xanomeline
How to manage this interaction
Keep taking both medicines exactly as prescribed unless your care team tells you otherwise. Because this concern is theoretical, the main step is simply keeping a closer eye on how you feel.
- Watch for stronger Ayvakit side effects such as swelling, unusual tiredness, nausea, bruising, or dizziness, and report them.
- Your team may monitor you more closely and can adjust your avapritinib dose if needed, individualized to you.
- Tell your pharmacist and oncologist that you take both, and check before starting any new medicine.
Do not stop or change either drug on your own.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Avapritinib and Trospium / Xanomeline together?
Cobenfy (xanomeline) may modestly raise avapritinib levels by briefly slowing gut CYP3A4, so watch for more avapritinib side effects and let your care team monitor and adjust as needed. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Avapritinib and Trospium / Xanomeline interaction?
It is rated moderate. Can be significant — usually manageable with monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Avapritinib and Trospium / Xanomeline interaction managed?
Keep taking both medicines exactly as prescribed unless your care team tells you otherwise. Because this concern is theoretical, the main step is simply keeping a closer eye on how you feel. Watch for stronger Ayvakit side effects such as swelling, unusual tiredness, nausea, bruising, or dizziness, and report them. Your team may monitor you more closely and can adjust your avapritinib dose if need… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Avapritinib or Trospium / Xanomeline need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there anything you'd monitor while I'm on both?
References (1)
- Citation #1
Keep reading about Avapritinib
Keep reading about Trospium / Xanomeline
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist